CorVel Announces Second Quarter Revenues an...(forward-looking statement for any reason...),Health
forward-looking statement for any reason.
CorVel Corporation
Quarterly Results - Income Statement (Unaudited)
Quarter and Six Months Ended September 30, 2007 and 2008
Quarter Ended Quarter Ended
Quarter ended September 30 September 30, 2007 September 30, 2008
Revenues 73,510,000 77,855,000
Cost of revenues 54,856,000 58,996,000
Gross profit 18,654,000 18,859,000
General and administrative 9,398,000 10,722,000
Income from operations 9,256,000 8,137,000
Income tax expense 3,624,000 3,173,000
Net income 5,632,000 4,964,000
Earnings Per Share:
Basic $0.41 $0.36
Diluted $0.40 $0.36
Weighted Shares
Basic 13,889,000 13,764,000
Diluted 14,062,000 13,960,000
Six months Six months
Six months ended September September 30, 2007 September 30, 2008
Revenues 147,847,000 156,056,000
Cost of revenues 111,012,000 117,264,000
Gross profit 36,835,000 38,792,000
General and administrative 18,475,000 21,529,000
Income from operations 18,360,000 17,263,000
Income tax expense 7,167,000 6,732,000
Net income 11,193,000 10,531,000
Earnings Per Share:
Basic $0.80 $0.76
Diluted $0.79
'/>"/>
| SOURCE CorVel Corporation Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. CorVel Announces Expanded Share Buyback
2. CorVel Announces Record Earnings
3. CorVel Announces Appearance at Bank of America Health Care Conference
4. CorVel to Present at UBS Global Healthcare Services Conference
5. CorVel Announces Record Earnings Per Share
6. CorVel Corporation Announces Resumption of Stock Repurchases
7. Psychemedics Corporation Announces Third Quarter Results
8. HealthFitness Announces 2008 Third Quarter Results
9. ATS Medical Announces Third Quarter Results
10. STERIS Corporation Announces Webcast of Analyst Conference
11. Barr Announces Approval of Generic Camptosar(R) Injection, 20 mg/mL
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |